{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T05:42:18Z","timestamp":1782884538636,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"L\u2019Oreal-UNESCO For Women in Science Middle East Regional Young Talents program"},{"DOI":"10.13039\/100008693","name":"Gulf Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008693","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leading House Middle East and North Africa (LH-MENA) research partnership grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16107-x","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:59:15Z","timestamp":1778158755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ITPP in early pancreatic zebrafish xenografts mildly impacts tumor cell death without interfering with vascular normalization"],"prefix":"10.1186","volume":"26","author":[{"given":"Raefa","family":"Abou Khouzam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Rifath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Thaliffdeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premalatha","family":"Ragupathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Nawafleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda","family":"Povoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Cruz-Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Lehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Fior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perparim","family":"Limani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salem","family":"Chouaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"1","key":"16107_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"16107_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10456-018-9645-2","volume":"22","author":"S Li","year":"2019","unstructured":"Li S, Xu HX, Wu CT, Wang WQ, Jin W, Gao HL, et al. Angiogenesis in pancreatic cancer: current research status and clinical implications. Angiogenesis. 2019;22(1):15\u201336.","journal-title":"Angiogenesis"},{"key":"16107_CR3","doi-asserted-by":"publisher","first-page":"680435","DOI":"10.3389\/fimmu.2021.680435","volume":"12","author":"R Abou Khouzam","year":"2021","unstructured":"Abou Khouzam R, Rao SP, Venkatesh GH, Zeinelabdin NA, Buart S, Meylan M, et al. An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment. Front Immunol. 2021;12:680435.","journal-title":"Front Immunol"},{"key":"16107_CR4","doi-asserted-by":"crossref","unstructured":"Abou Khouzam R, Lehn JM, Mayr H, Clavien PA, Wallace MB, Ducreux M, et al. Hypoxia, a targetable culprit to counter pancreatic cancer resistance to therapy. Cancers (Basel). 2023;15(4):1235.","DOI":"10.3390\/cancers15041235"},{"issue":"11","key":"16107_CR5","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1158\/0008-5472.CAN-22-2945","volume":"84","author":"BA Brown","year":"2024","unstructured":"Brown BA, Myers PJ, Adair SJ, Pitarresi JR, Sah-Teli SK, Campbell LA, et al. A Histone Methylation-MAPK Signaling Axis Drives Durable Epithelial-Mesenchymal Transition in Hypoxic Pancreatic Cancer. Cancer Res. 2024;84(11):1764\u201380.","journal-title":"Cancer Res"},{"issue":"5","key":"16107_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1158\/2767-9764.CRC-24-0025","volume":"5","author":"B Navarro-Serer","year":"2025","unstructured":"Navarro-Serer B, Wissler MF, Glover BK, Lerner MG, Oza HH, Wang V, et al. P4HA1 Mediates Hypoxia-Induced Invasion in Human Pancreatic Cancer Organoids. Cancer Res Commun. 2025;5(5):881\u201395.","journal-title":"Cancer Res Commun"},{"issue":"1","key":"16107_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12967-025-06292-x","volume":"23","author":"CC Ko","year":"2025","unstructured":"Ko CC, Yang PM. Hypoxia-induced MIR31HG expression promotes partial EMT and basal-like phenotype in pancreatic ductal adenocarcinoma based on data mining and experimental analyses. J Transl Med. 2025;23(1):305.","journal-title":"J Transl Med"},{"issue":"1","key":"16107_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41420-024-02035-x","volume":"10","author":"X Liu","year":"2024","unstructured":"Liu X, Huang Z, Chen Q, Chen K, Liu W, Liu G, et al. Hypoxia-induced epigenetic regulation of miR-485-3p promotes stemness and chemoresistance in pancreatic ductal adenocarcinoma via SLC7A11-mediated ferroptosis. Cell Death Discov. 2024;10(1):262.","journal-title":"Cell Death Discov"},{"issue":"1","key":"16107_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41435-024-00315-1","volume":"26","author":"X Zhou","year":"2025","unstructured":"Zhou X, Cai M, Yang F, Huang L, Ling Y, Zhang Y, et al. Hypoxia-induced autophagy in pancreatic cancer counteracts the cytotoxicity of CD8. Genes Immun. 2025;26(1):45\u201353.","journal-title":"Genes Immun"},{"issue":"11","key":"16107_CR10","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1080\/15476286.2019.1649585","volume":"16","author":"ZL Ou","year":"2019","unstructured":"Ou ZL, Luo Z, Wei W, Liang S, Gao TL, Lu YB. Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977\/miR-153 axis. RNA Biol. 2019;16(11):1592\u2013603.","journal-title":"RNA Biol"},{"key":"16107_CR11","doi-asserted-by":"publisher","first-page":"102261","DOI":"10.1016\/j.tranon.2024.102261","volume":"52","author":"A Tulamaiti","year":"2025","unstructured":"Tulamaiti A, Xiao SY, Yang Y, Mutailifu M, Li XQ, Yin SQ, et al. ENO1 promotes PDAC progression by inhibiting CD8. Transl Oncol. 2025;52:102261.","journal-title":"Transl Oncol"},{"issue":"3","key":"16107_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1053\/j.gastro.2024.10.042","volume":"168","author":"J Ding","year":"2025","unstructured":"Ding J, Xie Y, Liu Z, Zhang Z, Ni B, Yan J, et al. Hypoxic and Acidic Tumor Microenvironment-Driven AVL9 Promotes Chemoresistance of Pancreatic Ductal Adenocarcinoma via the AVL9-I\u03baB\u03b1-SKP1 Complex. Gastroenterology. 2025;168(3):539\u2013e555.","journal-title":"Gastroenterology"},{"issue":"1","key":"16107_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/00006676-200301000-00010","volume":"26","author":"P B\u00fcchler","year":"2003","unstructured":"B\u00fcchler P, Reber HA, B\u00fcchler M, Shrinkante S, B\u00fcchler MW, Friess H, et al. Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas. 2003;26(1):56\u201364.","journal-title":"Pancreas"},{"issue":"9","key":"16107_CR14","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/j.1445-2197.2006.03872.x","volume":"76","author":"G Garcea","year":"2006","unstructured":"Garcea G, Doucas H, Steward WP, Dennison AR, Berry DP. Hypoxia and angiogenesis in pancreatic cancer. ANZ J Surg. 2006;76(9):830\u201342.","journal-title":"ANZ J Surg"},{"issue":"6","key":"16107_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrd3455","volume":"10","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 2011;10(6):417\u201327.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"16107_CR16","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","volume":"26","author":"RK Jain","year":"2014","unstructured":"Jain RK. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. Cancer Cell. 2014;26(5):605\u201322.","journal-title":"Cancer Cell"},{"issue":"22","key":"16107_CR17","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1200\/JCO.2010.28.1386","volume":"28","author":"HL Kindler","year":"2010","unstructured":"Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, et al. Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). J Clin Oncol. 2010;28(22):3617\u201322.","journal-title":"J Clin Oncol"},{"key":"16107_CR18","doi-asserted-by":"crossref","unstructured":"Annese T, Tamma R, Ruggieri S, Ribatti D. Angiogenesis in pancreatic cancer: pre-clinical and clinical studies. Cancers (Basel). 2019;11(3):381.","DOI":"10.3390\/cancers11030381"},{"issue":"3","key":"16107_CR19","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","volume":"91","author":"S Goel","year":"2011","unstructured":"Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev. 2011;91(3):1071\u2013121.","journal-title":"Physiol Rev"},{"issue":"1","key":"16107_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"ZL Liu","year":"2023","unstructured":"Liu ZL, Chen HH, Zheng LL, Sun LP, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther. 2023;8(1):198.","journal-title":"Signal Transduct Target Ther"},{"issue":"18","key":"16107_CR21","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1002\/cbic.201000499","volume":"11","author":"CD Duarte","year":"2010","unstructured":"Duarte CD, Greferath R, Nicolau C, Lehn JM. myo-Inositol trispyrophosphate: a novel allosteric effector of hemoglobin with high permeation selectivity across the red blood cell plasma membrane. ChemBioChem. 2010;11(18):2543\u20138.","journal-title":"ChemBioChem"},{"issue":"42","key":"16107_CR22","doi-asserted-by":"publisher","first-page":"15576","DOI":"10.1073\/pnas.0607109103","volume":"103","author":"C Kieda","year":"2006","unstructured":"Kieda C, Greferath R, Crola da Silva C, Fylaktakidou KC, Lehn JM, Nicolau C. Suppression of hypoxia-induced HIF-1alpha and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes. Proc Natl Acad Sci U S A. 2006;103(42):15576\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"16107_CR23","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00109-013-0992-6","volume":"91","author":"C Kieda","year":"2013","unstructured":"Kieda C, El Hafny-Rahbi B, Collet G, Lamerant-Fayel N, Grillon C, Guichard A, et al. Stable tumor vessel normalization with pO\u2082 increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment. J Mol Med (Berl). 2013;91(7):883\u201399.","journal-title":"J Mol Med (Berl)"},{"issue":"5","key":"16107_CR24","doi-asserted-by":"publisher","first-page":"e0285318","DOI":"10.1371\/journal.pone.0285318","volume":"18","author":"M Krzykawska-Serda","year":"2023","unstructured":"Krzykawska-Serda M, Szczygie\u0142 D, Gawe\u0142 S, Drza\u0142 A, Szczygie\u0142 M, Kmie\u0107 MM, et al. Oxygen therapeutic window induced by myo-inositol trispyrophosphate (ITPP)-Local pO2 study in murine tumors. PLoS ONE. 2023;18(5):e0285318.","journal-title":"PLoS ONE"},{"issue":"2","key":"16107_CR25","doi-asserted-by":"publisher","first-page":"e70343","DOI":"10.1111\/jcmm.70343","volume":"29","author":"S Koj","year":"2025","unstructured":"Koj S, Niedziela T, Rossowska J, Schmitt JL, Lehn JM, Nicolau C, et al. Modulation of the Oxygenation State and Intracellular pH of Erythrocytes by Inositol-Trispyrophosphate Investigated by. J Cell Mol Med. 2025;29(2):e70343.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"16107_CR26","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1002\/ijc.28597","volume":"134","author":"Z Raykov","year":"2014","unstructured":"Raykov Z, Grekova SP, Bour G, Lehn JM, Giese NA, Nicolau C, et al. Myo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy. Int J Cancer. 2014;134(11):2572\u201382.","journal-title":"Int J Cancer"},{"issue":"23","key":"16107_CR27","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1158\/1078-0432.CCR-15-3112","volume":"22","author":"P Limani","year":"2016","unstructured":"Limani P, Linecker M, Kachaylo E, Tschuor C, Kron P, Schlegel A, et al. Antihypoxic Potentiation of Standard Therapy for Experimental Colorectal Liver Metastasis through Myo-Inositol Trispyrophosphate. Clin Cancer Res. 2016;22(23):5887\u201397.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"16107_CR28","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/SLA.0000000000002431","volume":"266","author":"P Limani","year":"2017","unstructured":"Limani P, Linecker M, Schneider MA, Kron P, Tschuor C, Kachaylo E, et al. The Allosteric Hemoglobin Effector ITPP Inhibits Metastatic Colon Cancer in Mice. Ann Surg. 2017;266(5):746\u201353.","journal-title":"Ann Surg"},{"issue":"1","key":"16107_CR29","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1038\/s41467-021-24069-w","volume":"12","author":"MA Schneider","year":"2021","unstructured":"Schneider MA, Linecker M, Fritsch R, Muehlematter UJ, Stocker D, Pestalozzi B, et al. Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors. Nat Commun. 2021;12(1):3807.","journal-title":"Nat Commun"},{"issue":"1","key":"16107_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s42003-020-1015-0","volume":"3","author":"C de Rebelo","year":"2020","unstructured":"de Rebelo C, Mendes RV, Pezzarossa A, Gago J, Carvalho C, Alves A, et al. Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy. Commun Biol. 2020;3(1):299.","journal-title":"Commun Biol"},{"issue":"1","key":"16107_CR31","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1038\/s41467-024-49051-0","volume":"15","author":"B Costa","year":"2024","unstructured":"Costa B, Estrada MF, Gomes A, Fernandez LM, Azevedo JM, P\u00f3voa V, et al. Zebrafish Avatar-test forecasts clinical response to chemotherapy in patients with colorectal cancer. Nat Commun. 2024;15(1):4771.","journal-title":"Nat Commun"},{"key":"16107_CR32","doi-asserted-by":"crossref","unstructured":"Martinez-Lopez M, P\u00f3voa V, Fior R. Generation of zebrafish larval xenografts and tumor behavior analysis. J Vis Exp. 2021(172):e62373.","DOI":"10.3791\/62373-v"},{"issue":"4","key":"16107_CR33","doi-asserted-by":"publisher","first-page":"e415","DOI":"10.1002\/cpz1.415","volume":"2","author":"B Costa","year":"2022","unstructured":"Costa B, Estrada MF, Barroso MT, Fior R. Zebrafish Patient-Derived Avatars from Digestive Cancers for Anti-cancer Therapy Screening. Curr Protoc. 2022;2(4):e415.","journal-title":"Curr Protoc"},{"issue":"1","key":"16107_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41698-025-00882-0","volume":"9","author":"RV Mendes","year":"2025","unstructured":"Mendes RV, Ribeiro JM, Gouveia H, Rebelo de Almeida C, Castillo-Martin M, Brito MJ, et al. Zebrafish Avatar testing preclinical study predicts chemotherapy response in breast cancer. NPJ Precis Oncol. 2025;9(1):94.","journal-title":"NPJ Precis Oncol"},{"key":"16107_CR35","doi-asserted-by":"crossref","unstructured":"Tavares Barroso M, Costa B, Rebelo de Almeida C, Castillo Martin M, Couto N, Carvalho T, et al. Establishment of pancreatobiliary cancer zebrafish avatars for chemotherapy screening. Cells. 2021;10(8):2077.","DOI":"10.3390\/cells10082077"},{"issue":"39","key":"16107_CR36","doi-asserted-by":"publisher","first-page":"E8234","DOI":"10.1073\/pnas.1618389114","volume":"114","author":"R Fior","year":"2017","unstructured":"Fior R, P\u00f3voa V, Mendes RV, Carvalho T, Gomes A, Figueiredo N, et al. Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts. Proc Natl Acad Sci U S A. 2017;114(39):E8234\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"16107_CR37","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/neuonc\/noab264","volume":"24","author":"E Almstedt","year":"2022","unstructured":"Almstedt E, Ros\u00e9n E, Gloger M, Stockgard R, Hekmati N, Koltowska K, et al. Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts. Neuro Oncol. 2022;24(5):726\u201338.","journal-title":"Neuro Oncol"},{"issue":"4","key":"16107_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1177\/15353702221142612","volume":"248","author":"X Hua","year":"2023","unstructured":"Hua X, Wu X, Xu K, Zhan P, Liu H, Zhang F, et al. Zebrafish patient-derived xenografts accurately and quickly reproduce treatment outcomes in non-small cell lung cancer patients. Exp Biol Med (Maywood). 2023;248(4):361\u20139.","journal-title":"Exp Biol Med (Maywood)"},{"key":"16107_CR39","doi-asserted-by":"crossref","unstructured":"Usai A, Di Franco G, Colucci P, Pollina LE, Vasile E, Funel N, et al. A model of a zebrafish avatar for co-clinical trials. Cancers (Basel). 2020;12(3):677.","DOI":"10.3390\/cancers12030677"},{"key":"16107_CR40","doi-asserted-by":"publisher","first-page":"102578","DOI":"10.1016\/j.ebiom.2019.11.039","volume":"51","author":"B Costa","year":"2020","unstructured":"Costa B, Ferreira S, P\u00f3voa V, Cardoso MJ, Vieira S, Stroom J, et al. Developments in zebrafish avatars as radiotherapy sensitivity reporters - towards personalized medicine. EBioMedicine. 2020;51:102578.","journal-title":"EBioMedicine"},{"key":"16107_CR41","doi-asserted-by":"publisher","first-page":"101162","DOI":"10.1016\/j.drup.2024.101162","volume":"78","author":"F Song","year":"2025","unstructured":"Song F, Yi X, Zheng X, Zhang Z, Zhao L, Shen Y, et al. Zebrafish patient-derived xenograft system for predicting carboplatin resistance and metastasis of ovarian cancer. Drug Resist Updat. 2025;78:101162.","journal-title":"Drug Resist Updat"},{"issue":"2","key":"16107_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.stem.2007.11.002","volume":"2","author":"RM White","year":"2008","unstructured":"White RM, Sessa A, Burke C, Bowman T, LeBlanc J, Ceol C, et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell. 2008;2(2):183\u20139.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"16107_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1006\/dbio.2002.0711","volume":"248","author":"ND Lawson","year":"2002","unstructured":"Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol. 2002;248(2):307\u201318.","journal-title":"Dev Biol"},{"issue":"7","key":"16107_CR44","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676\u201382.","journal-title":"Nat Methods"},{"issue":"4","key":"16107_CR45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1049\/htl.2018.5031","volume":"6","author":"Y Chang","year":"2019","unstructured":"Chang Y. Improving the Otsu method for MRA image vessel extraction via resampling and ensemble learning. Healthc Technol Lett. 2019;6(4):115\u201320.","journal-title":"Healthc Technol Lett"},{"issue":"5","key":"16107_CR46","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/cbic.201000619","volume":"12","author":"M Aprahamian","year":"2011","unstructured":"Aprahamian M, Bour G, Akladios CY, Fylaktakidou K, Greferath R, Soler L, et al. Myo-InositolTrisPyroPhosphate treatment leads to HIF-1\u03b1 suppression and eradication of early hepatoma tumors in rats. ChemBioChem. 2011;12(5):777\u201383.","journal-title":"ChemBioChem"},{"issue":"36","key":"16107_CR47","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1038\/onc.2012.445","volume":"32","author":"L Derbal-Wolfrom","year":"2013","unstructured":"Derbal-Wolfrom L, Pencreach E, Saandi T, Aprahamian M, Martin E, Greferath R, et al. Increasing the oxygen load by treatment with myo-inositol trispyrophosphate reduces growth of colon cancer and modulates the intestine homeobox gene Cdx2. Oncogene. 2013;32(36):4313\u20138.","journal-title":"Oncogene"},{"issue":"11","key":"16107_CR48","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","volume":"34","author":"T Conroy","year":"2023","unstructured":"Conroy T, Pfeiffer P, Vilgrain V, Lamarca A, Seufferlein T, O\u2019Reilly EM, et al. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(11):987\u20131002.","journal-title":"Ann Oncol"},{"issue":"5","key":"16107_CR49","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","volume":"164","author":"EM Stoffel","year":"2023","unstructured":"Stoffel EM, Brand RE, Goggins M. Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention. Gastroenterology. 2023;164(5):752\u201365.","journal-title":"Gastroenterology"},{"issue":"7446","key":"16107_CR50","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature12111","volume":"496","author":"K Howe","year":"2013","unstructured":"Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature. 2013;496(7446):498\u2013503.","journal-title":"Nature"},{"key":"16107_CR51","doi-asserted-by":"crossref","unstructured":"Costa B, Estrada MF, Mendes RV, Fior R. Zebrafish avatars towards personalized medicine-a comparative review between avatar models. Cells. 2020;9(2):293.","DOI":"10.3390\/cells9020293"},{"key":"16107_CR52","doi-asserted-by":"crossref","unstructured":"Varanda AB, Martins-Logrado A, Ferreira MG, Fior R. Zebrafish xenografts unveil sensitivity to olaparib beyond BRCA status. Cancers (Basel). 2020;12(7):1769.","DOI":"10.3390\/cancers12071769"},{"issue":"5","key":"16107_CR53","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/bjc.2013.429","volume":"109","author":"NS Vasudev","year":"2013","unstructured":"Vasudev NS, Goh V, Juttla JK, Thompson VL, Larkin JM, Gore M, et al. Changes in tumour vessel density upon treatment with anti-angiogenic agents: relationship with response and resistance to therapy. Br J Cancer. 2013;109(5):1230\u201342.","journal-title":"Br J Cancer"},{"key":"16107_CR54","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1146\/annurev-physiol-020518-114700","volume":"81","author":"JD Martin","year":"2019","unstructured":"Martin JD, Seano G, Jain RK. Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges. Annu Rev Physiol. 2019;81:505\u201334.","journal-title":"Annu Rev Physiol"},{"issue":"6","key":"16107_CR55","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/jcmm.17699","volume":"27","author":"K Grzymajlo","year":"2023","unstructured":"Grzymajlo K, El Hafny-Rahbi B, Kieda C. Tumour suppressor PTEN activity is differentially inducible by myo-inositol phosphates. J Cell Mol Med. 2023;27(6):879\u201390.","journal-title":"J Cell Mol Med"},{"key":"16107_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trsl.2022.08.015","volume":"253","author":"F Sensi","year":"2023","unstructured":"Sensi F, D\u2019angelo E, Biccari A, Marangio A, Battisti G, Crotti S, et al. Establishment of a human 3D pancreatic adenocarcinoma model based on a patient-derived extracellular matrix scaffold. Transl Res. 2023;253:57\u201367.","journal-title":"Transl Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16107-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16107-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16107-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:28:09Z","timestamp":1782880089000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16107-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16107"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16107-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The zebrafish study protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at Gulf Medical University and the Champalimaud Animal Welfare & Ethical Review Body (ORBEA) at the Champalimaud Foundation. In vivo experiments were conducted in accordance with the European animal welfare Legislation, Directive 2010\/63\/EU (European Commission, 2016).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Professor Jean-Marie Lehn is co-founder and chairman of the scientific advisory board of NormOxys\n                      \u00ae\n                      , Inc., this being the company that holds the patent on ITPP. J.M.L. confirms this has no bearing on the objectivity or the conclusions presented in this manuscript, and all data has been handled impartially.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"787"}}